STOCK TITAN

Ascend Wellness Holdings Closes $50 Million Private Placement of Senior Secured Notes

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
private placement

Ascend Wellness Holdings (AAWH) has successfully closed a $50 million private placement of 12.75% Senior Secured Notes due 2029. These notes are part of the same series as previously issued notes, bringing the total aggregate principal amount to $300 million. The notes were issued at 97.5% of face value and will mature on July 16, 2029.

The company plans to use the net proceeds, along with cash on hand, to prepay its existing term loan, including accrued interest and transaction expenses. The notes bear a 12.75% annual interest rate, payable semi-annually, and are secured by substantially all assets of the company and certain subsidiaries. Seaport Global Securities LLC acted as the lead financial advisor and sole placement agent for the transaction.

Loading...
Loading translation...

Positive

  • Strong demand and lender support demonstrates market confidence in the company
  • Refinancing strengthens balance sheet and positions company for market opportunities
  • Notes are secured by company assets, providing protection for investors
  • Company maintains ability to redeem notes early at specified prices

Negative

  • High interest rate of 12.75% represents significant debt servicing cost
  • Notes issued at 97.5% of face value, representing a discount
  • Long-term debt commitment extends to 2029
  • Additional debt burden could impact financial flexibility

News Market Reaction 1 Alert

+5.91% News Effect

On the day this news was published, AAWH gained 5.91%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, May 28, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, is pleased to announce it has closed a private placement of $50 million of its 12.75% Senior Secured Notes due 2029 (the "Notes"). The Notes form part of the same series of the $250 million aggregate principal amount of the Company's 12.75% senior secured notes due 2029, of which $235 million aggregate principal amount was issued on July 16, 2024 and $15 million aggregate principal amount was issued on January 13, 2025. The Notes were issued at a price of 97.5% of face value pursuant to and governed by a trust indenture entered into as of July 16, 2024, as amended and supplemented by a first supplemental indenture dated as of January 13, 2025. The Company intends to use the net proceeds of the Notes, together with cash on hand, to prepay the total principal amounts outstanding under its existing term loan, along with accrued interest and other transaction-related expenses.

"This refinancing was always part of our long-term strategic plan, and we're very pleased with the strong demand and support from our lenders," said Sam Brill, Chief Executive Officer. "Their continued confidence in our team and plan underscores the long-term value of our business and the discipline with which we manage our operations. With a strong balance sheet, we are well-positioned to take advantage of current market conditions and execute on our densification strategy, while continuing to deliver value to all stakeholders."

Seaport Global Securities LLC (the "Agent") acted as lead financial advisor and sole placement agent for the Notes. Foley Hoag LLP and Stikeman Elliott LLP acted as legal advisors to Ascend, and Osler, Hoskin & Harcourt LLP acted as legal advisor to the Agent in connection with the transaction.

The Notes are senior secured obligations of the Company and bear interest at a rate of 12.75% per annum, payable semi-annually in arrears until their maturity date, unless earlier redeemed or repurchased in accordance with their terms. The Notes will mature on July 16, 2029. At any time and from time to time, the Company may redeem all or a part of the Notes at certain specified redemption prices, including until July 15, 2026, at par. The Notes are irrevocably and unconditionally guaranteed, jointly and severally, on a senior secured basis, by certain of the Company's subsidiaries (the "Guarantees"). The Notes and the Guarantees are secured, on a first lien basis, by substantially all assets of the Company and certain of its subsidiaries, subject to certain carveouts.

The Notes were sold in the United States to or for the account or benefit of "U.S. persons" (as defined in the United States Securities Act of 1933, as amended (the "U.S. Securities Act")), on a private placement basis to "qualified institutional buyers" and "accredited investors" pursuant to an exemption from the registration requirements of the U.S. Securities Act. The Notes were also offered on a private placement basis in certain provinces and territories of Canada pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws, and in such jurisdictions outside of Canada and the United States as was agreed upon by the Agent and the Company, in each case in accordance with applicable laws. The Notes are subject to a customary four-month hold period under Canadian securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Ascend Wellness Holdings, Inc.
AWH is a vertically integrated operator with assets in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio and Pennsylvania. AWH owns and operates state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers. AWH produces and distributes its in-house Common Goods, Simply Herb, Ozone, Ozone Reserve, Effin', and Royale branded products. For more information about Ascend, visit www.awholdings.com.

Cautionary Note Regarding Forward-Looking Information
This news release includes forward-looking information and statements (together, "forward-looking statements"), which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of the Company. Words such as "expects", "will", and "intends" or similar expressions are intended to identify forward-looking statements. Without limiting the generality of the preceding statement, this news release contains forward-looking statements concerning the intended use of proceeds, the expectations of the Company and other matters. We caution investors that any such forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience of the Company and its perception of historical trends, current conditions and expected future developments, and other factors management believes are appropriate.

Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein. Such factors include, among others, the risks and uncertainties identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and in the Company's other reports and filings with the applicable Canadian securities regulators on its profile on SEDAR+ at www.sedarplus.ca and with the SEC on its profile on EDGAR at www.sec.gov. Although the Company believes that any forward-looking statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such forward-looking statements, there can be no assurance that any such forward-looking statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking statements. Any forward-looking statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ascend-wellness-holdings-closes-50-million-private-placement-of-senior-secured-notes-302467516.html

SOURCE Ascend Wellness Holdings, Inc.

FAQ

What is the size and interest rate of AAWH's new senior secured notes?

AAWH issued $50 million in senior secured notes with a 12.75% interest rate, payable semi-annually, maturing in 2029.

How will Ascend Wellness use the proceeds from the $50M notes offering?

The company will use the net proceeds, combined with cash on hand, to prepay the outstanding principal under its existing term loan, along with accrued interest and transaction-related expenses.

What is the total aggregate amount of AAWH's 2029 senior secured notes?

The total aggregate amount is $300 million, consisting of $235 million issued in July 2024, $15 million in January 2025, and this new $50 million issuance.

What security backs AAWH's senior secured notes?

The notes are secured on a first lien basis by substantially all assets of the company and certain subsidiaries, with joint and several guarantees from specific subsidiaries.

When can AAWH redeem these senior secured notes?

The company can redeem all or part of the notes at any time at specified redemption prices, including at par until July 15, 2026.
Ascend Wellness

OTC:AAWH

AAWH Rankings

AAWH Latest News

AAWH Latest SEC Filings

AAWH Stock Data

140.18M
162.34M
29.61%
11.53%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Morristown